Article Information
History
- November 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Usha Padmanabhan, PhD1,#,*,
- Sanjay Mukherjee, MBBS2,#,
- Rohidas Borse, MD3,
- Sameer Joshi, MD3 and
- Rajesh Deshmukh, MVSC1
- 1Haffkine Institute for Training, Research & Testing, Acharya Donde Marg, Parel, 400 012
- 2Medical Education & Drugs department, 9th floor, GT Hospital Campus, Mumbai 400 001
- 3Department of Medicine, BJ Medical College and Sassoon General Hospital, Pune 410 001
- ↵*Corresponding author: Dr. Usha Padmanabhan, Address: Biochemistry department, Haffkine Institute for Training, Research & Testing, Acharya, Donde Marg, Parel, Mumbai 400 012. Email: u.padmanabhan{at}haffkineinstitute.org, Contact: +91 022 24160947, Cell: +91 9773322311
↵# Both authors must be considered as first authors who contributed equally to the work.
Posted November 03, 2020.
Phase II Clinical trial for Evaluation of BCG as potential therapy for COVID-19
